A prospective, multicenter study on hematopoietic stem-cell mobilization with cyclophosphamide plus granulocyte colony-stimulating factor and 'on-demand' plerixafor in multiple myeloma patients treated with novel agents
Articolo
Data di Pubblicazione:
2023
Abstract:
: High-dose melphalan plus autologous stem-cell transplantation (ASCT) is a standard of care for transplant-eligible patients with newly diagnosed multiple myeloma (NDMM), and adequate hematopoietic stem-cell (HSC) collection is crucial to ensure hematologic recovery after ASCT. In this prospective, observational study we evaluated HSC mobilization with granulocyte colony-stimulating factor (G-CSF), cyclophosphamide, and 'on-demand' plerixafor (in patients with.
Tipologia CRIS:
03A-Articolo su Rivista
Elenco autori:
Mina, Roberto; Petrucci, Maria Teresa; Bonello, Francesca; Bongarzoni, Velia; Saccardi, Riccardo; Bertuglia, Giuseppe; Mengarelli, Andrea; Spadaro, Andrea; Lisi, Chiara; Curci, Paola; Lemoli, Roberto Massimo; Ballanti, Stelvio; Floris, Rita; Cupelli, Luca; Tosi, Patrizia; Olivieri, Attilio; Rota-Scalabrini, Delia; Cangialosi, Clotilde; Nozzoli, Chiara; Anaclerico, Barbara; Fazio, Francesca; Bruno, Benedetto; Mancuso, Katia; Corradini, Paolo; Milone, Giuseppe; Boccadoro, Mario
Link alla scheda completa:
Link al Full Text:
Pubblicato in: